1. Home
  2. ZLAB vs MTX Comparison

ZLAB vs MTX Comparison

Compare ZLAB & MTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

SELL

Current Price

$22.62

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Logo Minerals Technologies Inc.

MTX

Minerals Technologies Inc.

SELL

Current Price

$63.55

Market Cap

2.2B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
ZLAB
MTX
Founded
2013
1968
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2017
2004

Fundamental Metrics

Financial Performance
Metric
ZLAB
MTX
Price
$22.62
$63.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
4
Target Price
$33.14
★ $91.25
AVG Volume (30 Days)
★ 712.3K
154.9K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
★ 0.75%
EPS Growth
★ 38.46
N/A
EPS
★ N/A
N/A
Revenue
$460,156,000.00
★ $2,072,600,000.00
Revenue This Year
N/A
$5.37
Revenue Next Year
$26.50
$4.81
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.33
N/A
52 Week Low
$15.96
$53.94
52 Week High
$30.00
$84.34

Technical Indicators

Market Signals
Indicator
ZLAB
MTX
Relative Strength Index (RSI) 34.34 30.85
Support Level $16.97 N/A
Resistance Level $27.14 $70.21
Average True Range (ATR) 1.03 1.20
MACD -0.36 -0.10
Stochastic Oscillator 9.48 8.06

Price Performance

Historical Comparison
ZLAB
MTX

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.

Share on Social Networks: